Expanded Access Postings Not Promotional, Unless Done In ‘Promotional Context,’ US FDA Says - Pink Sheet
Updated guidance on expanded access program clarifies that sponsors do not risk enforcement for off-label promotion if they post investigational drug expanded access policies, although that fear already may have subsided.